COVID-19 INFO #4 Data Collection in 35+ Countries

This series of INFO posts is designed to keep you updated with the key developments in our...

Planning a Tracking Study: Aligning Marketing and Market Research Teams

In an increasingly competitive landscape, pharmaceutical companies are required to assess the...

French GPs React to COVID-19: AplusA Poll Wave 4

The latest results from our ongoing poll among French GPs monitoring their experiences and...

French GPs React to COVID-19: Results from AplusA Poll Wave 3

The latest results from our ongoing poll among French GPs monitoring their experiences and...

French GPs React to COVID-19: Results from AplusA Poll Waves 1 and 2

General practitioners are an essential line of defense within the healthcare system in the fight...

COVID-19 INFO #3: Data Collection and More

As the COVID-19 situation develops and as AplusA teams have been receiving questions regarding...

COVID-19 INFO #2: HCP Respondent Response

As the COVID-19 situation develops we want to keep our clients and community updated on the...

Coronavirus: The Evolution of its Many Names

AplusA utilized social media analysis tools to observe the evolution of the use of the different...

COVID-19 INFO #1: Data Collection

AplusA teams have been receiving questions regarding the impact of COVID-19 on market research...

COVID-19 Message of Thanks to AplusA Healthcare Professional Study Participants

Doctor Christine Maï, AplusA Executive Vice-President, sent the following message to the...